José Baselga,et al: Biomarker Analysis Identified Women Most Likely to Benefit From T-DM1

AACR 2013 Pressconference April 6: "Late Breaking Clinical Trials" José Baselga,et al: Relationship between tumor biomarkers (BM) and efficacy in EMILIA, a phase 3 study of trastuzumab emt... Author: feeds Added: 04/11/2013
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts